These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 463893)

  • 21. [Tetrodotoxin potentiation of the antiarrhythmic action of lidocaine in the late stage of experimental myocardial infarct].
    Rozenshtraukh LV; Aniukhovskiĭ EP; Beloshapko GG
    Biull Eksp Biol Med; 1981; 91(1):38-40. PubMed ID: 6163491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Slower lidocaine elimination and dose adjustment in patients with heart failure].
    Follath F; Ritz R; Vozeh S; Wenk M
    Schweiz Med Wochenschr; 1982 May; 112(22):789-91. PubMed ID: 6808662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapy with antiarrhythmic drugs.
    Goldman P; Ingelfinger JA
    N Engl J Med; 1978 May; 298(21):1193-4. PubMed ID: 651949
    [No Abstract]   [Full Text] [Related]  

  • 24. Prophylactic lidocaine in suspected acute myocardial infarction.
    Goodman SL; Geiderman JM; Bernstein IJ
    JACEP; 1979 Jun; 8(6):221-4. PubMed ID: 449144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epicardial, endocardial and transmural mapping in assessing electrophysiological effects of 14-C lidocaine and 14-C propafenone on activation times in experimental chronic myocardial infarction. Correlations with myocardial drugs concentrations.
    Naccarella FF; Agarwal JB; Weintraub WS; Bracchetti D; Helfant RH
    G Ital Cardiol; 1984 Oct; 14(10):825-9. PubMed ID: 6519392
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lidocaine kinetics predicted by indocyanine green clearance.
    Zito RA; Reid PR
    N Engl J Med; 1978 May; 298(21):1160-3. PubMed ID: 651945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pharmacokinetics of lidocaine after intramuscular injection in patients with acute myocardial infarction (author's transl)].
    Oltmanns D; Siegers CP
    Z Kardiol; 1979 Mar; 68(3):131-6. PubMed ID: 442753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective controlled randomized trial of prophylactic antiarrhythmic therapy in postmyocardial infarction patients with asymptomatic ventricular arrhythmias--study design and initial results.
    Pfisterer M; Burkart F; Follath F; Burckhardt D
    Clin Cardiol; 1988 Mar; 11(3 Suppl 2):II41-5. PubMed ID: 3078156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lidocaine and the quarternary ammonium compound QX-572 in acute myocardial infarction. A comparative study.
    Bergdahl B; Karlsson E; Magnusson JO; Sonnhag C
    Acta Med Scand; 1978; 204(4):311-4. PubMed ID: 358766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blood levels of lidocaine after various infusion rates in patients with acute myocardial infarction.
    Rydén L; Waldenström A; Winsnes Y; Ortengren B
    Am Heart J; 1975 Apr; 89(4):470-3. PubMed ID: 1114978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative pharmacodynamics of intravenous lidocaine in patients with acute and chronic ventricular arrhythmias.
    Hilleman DE; Mohiuddin SM; Mooss AN; Hunter CB; Destache CJ; Sketch MH
    Ann Pharmacother; 1992 Jun; 26(6):763-7. PubMed ID: 1611156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A controlled trial of intramuscular lidocaine in the prevention of premature ventricular contractions associated with acute myocardial infarction.
    Singh JB; Kocot SL
    Am Heart J; 1976 Apr; 91(4):430-6. PubMed ID: 1258750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of intracoronary lidocaine on ventricular arrhythmia in the infarcted canine heart.
    Tordjman T; Raeder E; Lampert S; Lown B
    Pharmacotherapy; 1988; 8(5):295-8. PubMed ID: 3252195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple bolus technique for lidocaine administration in acute ischemic heart disease. II. Treatment of refractory ventricular arrhythmias and the pharmacokinetic significance of severe left ventricular failure.
    Wyman MG; Slaughter RL; Farolino DA; Gore S; Cannom DS; Goldreyer BN; Lalka D
    J Am Coll Cardiol; 1983 Oct; 2(4):764-9. PubMed ID: 6886235
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of duration of lidocaine infusion and route of cimetidine administration on lidocaine pharmacokinetics.
    Powell JR; Foster J; Patterson JH; Cross R; Wargin W
    Clin Pharm; 1986 Dec; 5(12):993-8. PubMed ID: 3802729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Lidocaine pharmacokinetics and substantiation of the new method of its administration in myocardial infarct].
    Piotrovskiĭ VK; Smirnova EB; Riabokon' OS; Mazur NA; Metelitsa VI
    Kardiologiia; 1979 Jul; 19(7):23-7. PubMed ID: 470315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of lidocaine-infusion phlebitis by heparin and hydrocortisone.
    Bassan MM; Sheikh-Hamad D
    Chest; 1983 Oct; 84(4):439-41. PubMed ID: 6617280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Excessive serum lidocaine levels during maintenance infusions: mechanisms and prevention.
    Davison R; Parker M; Atkinson AJ
    Am Heart J; 1982 Aug; 104(2 Pt 1):203-8. PubMed ID: 7102503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Observations on intravenous administration of lignocaine in patients with myocardial infarction.
    Campbell NP; Kelly JG; Adgey AA; McDevitt DG; Pantridge JF
    Br Heart J; 1978 Dec; 40(12):1371-5. PubMed ID: 737094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of antiarrhythmic effects of oral prajmalium bitartrate and intravenous lidocaine in acute myocardial infarction.
    Bussmann WD; Schreiber S; Kaltenbach M
    Am Heart J; 1980 May; 99(5):589-97. PubMed ID: 7369098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.